TP53 and acute myeloid leukemia: PD-L1 overexpression in AML blasts is associated with inferior clinical outcome in patients with mutated nucleophosmin and concomitant internal tandem duplications in the FLT3 gene (138), and positively correlated with poor risk cytogenetic and TP53 expression (139).